Cargando…
Selective serotonin reuptake inhibitor (SSRI) antidepressants reduce COVID-19 infection: prospects for use
PURPOSE: The absence of specific treatments for COVID-19 leads to an intense global effort in the search for new therapeutic interventions and better clinical outcomes for patients. This review aimed to present a selection of accepted studies that reported the activity of antidepressant drugs belong...
Autores principales: | Foletto, Vitória Segabinazzi, da Rosa, Taciéli Fagundes, Serafin, Marissa Bolson, Hörner, Rosmari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360648/ https://www.ncbi.nlm.nih.gov/pubmed/35943535 http://dx.doi.org/10.1007/s00228-022-03372-5 |
Ejemplares similares
-
Anti-infective properties of proton pump inhibitors: perspectives
por: da Rosa, Taciéli Fagundes, et al.
Publicado: (2021) -
Drug repositioning is an alternative for the treatment of coronavirus COVID-19
por: Serafin, Marissa B., et al.
Publicado: (2020) -
Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer
por: Ashbury, Janet E., et al.
Publicado: (2012) -
Drug repositioning, a new alternative in infectious diseases
por: Serafin, Marissa Bolson, et al.
Publicado: (2018) -
Abnormal Thyroid Function Laboratory Results Caused by Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressant Treatment
por: Liao, Huijuan, et al.
Publicado: (2023)